Trials / Conditions / Philadelphia Positive Acute Lymphoblastic Leukemia

Philadelphia Positive Acute Lymphoblastic Leukemia

8 registered clinical trials studyying Philadelphia Positive Acute Lymphoblastic Leukemia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ NCT06481228	Institute of Hematology & Blood Diseases Hospital, China	N/A
Unknown	A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL NCT05024357	First Affiliated Hospital Xi'an Jiaotong University	N/A
Unknown	A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL NCT05026229	First Affiliated Hospital Xi'an Jiaotong University	N/A
Recruiting	Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL NCT04260022	Ascentage Pharma Group Inc.	Phase 1
Completed	SCT in Ph Positive Acute Lymphoblastic Leukemia NCT03821727	CANDONI ANNA	—
Completed	Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia NCT01914484	University Health Network, Toronto	Phase 1 / Phase 2
Completed	Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemi NCT01724879	Goethe University	Phase 2
Unknown	Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute L NCT00199186	Johann Wolfgang Goethe University Hospital	Phase 2